DREAMM-7

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

DREAMM-7

Jul 28, 2024, 12:28 | Insight

Ross Firestone: Antigen escape with BCMA-targeting therapies in multiple myeloma

Ross Firestone, Hematology/Oncology Fellow at Memorial Sloan Kettering Cancer Center, shared a post on X…

Jul 14, 2024, 02:56 | Drugs

Belamaf-based triplet regimens are effective in patients with R/R multiple myeloma - ASCO

ASCO shared on X: "The DREAMM-7 and DREAMM-8 studies established the effectiveness of belamaf-based triplet…

Jun 7, 2024, 14:45 | Blog

Manni Mohyuddin on DREAMM-7

Manni Mohyuddin shared on X/Twitter: "In DREAMM-7 (bela/bort/dex vs dara/bort/dex). Only 34% of pts len refractory.…

Jun 2, 2024, 15:31 | Insight

Myeloma Paper of the Day, June 2nd, suggested by Robert Orlowski

Robert Orlowski shared on X: "Myeloma Paper of the Day: DREAMM-7 study shows belantamab/bortezomib/dexamethasone superior…

Jan 14, 2024, 17:54 | Insight

Toni Choueiri: The February ASCO Plenary Series are here

Toni Choueiri posted on X/Twitter: "The February ASCO Plenary Series are here: Why??? Well...'Because Science can't…

All: 5 Posts: 1 - 100

'

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023